Robert Azelby, EVP & Chief Commercial Officer at Juno Therapeutics, Inc. (JUNO), sold 8,334 shares at $85.78 ($715K) on 2018-02-01, disclosed to the SEC on 2018-02-02.
Open-market sale of $715k JUNO by EVP & Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $85.78 | 4,167 | $357K | 50.0% |
| 2 | $85.78 | 4,167 | $357K | 50.0% |
| Total | $85.78 avg | 8,334 | $715K | 100% |
| Filing → |
| JUNO | SELL | 2018-02-14 | $356K | — | Filing → |
| JUNO | SELL | 2018-02-09 | $600K | — | Filing → |
| JUNO | SELL | 2018-01-24 | $17.7M | — | Filing → |